4-Hydroxynonenal impairs miRNA maturation in heart failure via Dicer post-translational modification
- PMID: 37944136
- DOI: 10.1093/eurheartj/ehad662
4-Hydroxynonenal impairs miRNA maturation in heart failure via Dicer post-translational modification
Abstract
Background and aims: Developing novel therapies to battle the global public health burden of heart failure remains challenging. This study investigates the underlying mechanisms and potential treatment for 4-hydroxynonenal (4-HNE) deleterious effects in heart failure.
Methods: Biochemical, functional, and histochemical measurements were applied to identify 4-HNE adducts in rat and human failing hearts. In vitro studies were performed to validate 4-HNE targets.
Results: 4-HNE, a reactive aldehyde by-product of mitochondrial dysfunction in heart failure, covalently inhibits Dicer, an RNase III endonuclease essential for microRNA (miRNA) biogenesis. 4-HNE inhibition of Dicer impairs miRNA processing. Mechanistically, 4-HNE binds to recombinant human Dicer through an intermolecular interaction that disrupts both activity and stability of Dicer in a concentration- and time-dependent manner. Dithiothreitol neutralization of 4-HNE or replacing 4-HNE-targeted residues in Dicer prevents 4-HNE inhibition of Dicer in vitro. Interestingly, end-stage human failing hearts from three different heart failure aetiologies display defective 4-HNE clearance, decreased Dicer activity, and miRNA biogenesis impairment. Notably, boosting 4-HNE clearance through pharmacological re-activation of mitochondrial aldehyde dehydrogenase 2 (ALDH2) using Alda-1 or its improved orally bioavailable derivative AD-9308 restores Dicer activity. ALDH2 is a major enzyme responsible for 4-HNE removal. Importantly, this response is accompanied by improved miRNA maturation and cardiac function/remodelling in a pre-clinical model of heart failure.
Conclusions: 4-HNE inhibition of Dicer directly impairs miRNA biogenesis in heart failure. Strikingly, decreasing cardiac 4-HNE levels through pharmacological ALDH2 activation is sufficient to re-establish Dicer activity and miRNA biogenesis; thereby representing potential treatment for patients with heart failure.
Keywords: Aldehyde; Cardiac diseases; Mitochondria; Oxidative stress; Therapy.
© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Comment in
-
Post-translational modifications upon mitochondrial dysfunction in heart failure.Eur Heart J. 2023 Nov 21;44(44):4713-4714. doi: 10.1093/eurheartj/ehad710. Eur Heart J. 2023. PMID: 37939789 No abstract available.
MeSH terms
Substances
Grants and funding
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil
- R01 AA011147/AA/NIAAA NIH HHS/United States
- 2013/07937-8/Fundação de Amparo à Pesquisa do Estado de São Paulo
- 303281/2015-4/Conselho Nacional de Pesquisa e Desenvolvimento-Brasil
- APQ-03551-18/Fundação de Amparo à Pesquisa do Estado de Minas Gerais
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous
